| (V1589) |
Bleeding complications after implantation of active cardiovascular implantable devices in an era of triple therapy and novel antithrombotic drugs. |
|
L. Heimbaecher, G. Senel, S. Sandrock, C. Wulff, T. Demming, H. Bonnemeier (Kiel) |
| (V1590) |
LV-Funktionsverbesserung nach prophylaktischer ICD-Therapie bei dilatativer Kardiomyopathie |
|
E. Efimova, N. Timmesfeld, W. Grimm (Leipzig, Marburg) |
| (V1591) |
Long-term follow up and variables predicting arrhythmia recurrence of ICD patients with idiopathic ventricular fibrillation |
|
J. Siebermair, R. Wakili, E. Martens, B. M. Beckmann, M. F. Sinner, S. Clauß, F. V. Schüßler, H. L. Estner, S. Kääb (München) |
| (V1592) |
Occurrence of Ventricular Arrhythmias in ICD-Patients with Hypertrophic Cardiomyopathy and Late Gadolinum Enhancement in Cardiovascular Magnetic Resonance |
|
M. Schüler, H. Abdel-Aty, T. Hees, F. André, S. Lehrke, H. Steen, H. A. Katus (Heidelberg) |
| (V1593) |
Antitachycardia pacing efficacy in the setting of prolonged arrhythmia detection settings: insights into the ADVANCE III study |
|
J. O. Schwab, B. Lemke, A. Kloppe, E. Santi, A. Proclemer , ADVANCE (Bonn, Lüdenscheid, Bochum; Rome, Udine, IT) |
| (V1594) |
Role of antitachycardia Pacing in patients at high risk of ventricular fibrillation and polymorphic ventricular tachycardia |
|
H. Pavaci, C. Jilek, T. Reents, S. Ammar, S. Fichtner, G. Heßling, I. Deisenhofer, C. Kolb (München) |